
usd feb pm et
summari compani design manufactur market invisalign proprietari system
treat malocclus misalign teeth
price-to-earnings oper ep
risk assess reflect histor volatil
natur demand elect medic procedur
 oversea compani rel narrow
product focu increas risk revenu
shortfal rel compani guidanc
forecast threat legal battl
protect compani intellectu properti
apr ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
feb pm stock trade
expect revenu growth
follow greater growth
revenu growth like
dampen outbreak
novel coronaviru china
key growth market --
repres approxim total
revenu long run see grow
penetr intern market
 teen market key driver invisalign
despit anticip neg impact
expect algn oper
margin improv
pressur
temporari weak key end market
corpor structur reorgan
invest market expans
intern oper
sell product razorblad model
algn proprietari scanner use
gener invisalign treatment thu
increas sale scanner like lead
increas sale align despit
market concern competit pressur
algn scanner servic sale
suggest
continu drive high sale growth
next year
think share trade
forward earn estim room
appreci trade high
multipl think well warrant
expect compani earn grow
next sever year compound-annual-growth-rate
rang well peer addit
believ competit threat
recent overst see
long-term strength busi
support robust growth scanner sale
grow penetr teen
risk recommend target price
elect dental procedur
customer/competitor pushback
practic weaker-than-expect growth
key end market orthodont
procedur typic consid
medic necessari demand treatment
could fall sharpli face weaker
target base
ep
premium warrant given top-
compar forward price-to-earnings rang
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
senior vice presid
senior vice-president
senior vice-president chief legal
cfo senior vice-president global
corpor overview inc global medic devic compani engag
design manufactur market invisalign clear align itero intraor scanner servic
orthodont restor aesthet dentistri algn product intend primarili
treatment malocclus misalign teeth
two oper segment clear align scanner servic scanner year
end decemb clear align net revenu repres approxim world-wide net
revenu scanner net revenu repres remain world-wide net revenu sell
vast major product directli custom orthodontist gener practition dentist
well restor aesthet dentist includ prosthodontist periodontist oral
industri background malocclus misalign teeth one preval clinic
dental condit affect billion peopl approxim popul annual
approxim million peopl major develop countri elect treatment orthodontist world-wide
orthodont patient treat use tradit method metal arch wire
bracket refer brace may augment elast metal expand headgear
function applianc ancillari devic need upon complet treatment dental
profession may discret patient use retain applianc million
annual orthodont case start approxim million applic invisalign treatment
addit approxim million peopl malocclus could benefit straighten
teeth unlik seek treatment doctor offic
intraor scan emerg technolog sell could substanti impact
futur dentistri enabl dental practition creat imag patient teeth
digit scan use handheld intraor scanner insid mouth digit scan effici
precis comfort patient compar discomfort subject natur take
physic impress digit scan model accur physic impress
substanti reduc rate restor remak patient recal less often
appoint time restor shorter fewer adjust result greater
overal patient satisfact digit model file use variou procedur servic
includ fabric physic dental model use lab creat restor unit veneer
inlay onlay crown bridg implant abut digit record storag orthodont diagnosi
orthodont retain applianc invisalign digit impress submiss
busi strategi aim establish invisalign system standard method treat
malocclus intraor scan platform prefer scan protocol digit scan
algn strateg driver intern expans orthodontist util gener practition
gp treatment referr patient demand convers
major develop part corpor structur reorgan
reloc european headquart switzerland netherland result signific
one-tim tax benefit defer tax benefit start amort continu subsequ
year distort compar result result begin began present
non-gaap measur show underli perform
august file anti-trust complaint domin orthodont
scanner market accord primari competitor scanner market share
 orthodont treatment scanner market fallen precipit stop accept
scan august anti-trust complaint estim manufactur
sell least clear align complaint also highlight itero scanner
close system design specif send digit scan order invisalign clear
align dental profession send digit scan rival clear align incur addit fee
cost henc dental profession effect lock exclus order invisalign
purchas itero scanner may point competitor scanner
market howev sirona cerec omnicam definit scanner primarili design
orthodont treatment result take much longer scan patient entir mouth itero
decemb estim would take least two year anti-trust case
make trial assum claim surviv align pend motion dismiss
eventu pre-trial motion word see complaint signific risk
near futur
financi trend gener billion revenu reflect year-over-year
growth five-year compound annual growth rate compound-annual-growth-rate compani earn expand
reflect five-year compound-annual-growth-rate believ compani maintain
revenu earn cagr next sever year septemb
report debt balanc sheet compani histor debt balanc sheet
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli under-valued usd
neutral sinc januari technic indic
neutral
figur base fiscal year-end price
growth rate averag
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
mdr go effect may
follow vitro devic
regul ivdr goe effect
compani made much commentari
around introduct mdr
reason believ new regul could
neg impact industri exampl
juli submit letter
world trade organ request mdr
ivdr delay three year also
trade associ critic slow
piecem implement new
 health suppli index
rose slightli gain
 health
decreas composit index
neutral fundament outlook
health care suppli sub-industri next
current appear posit due strong
custom demand concern
possibl signific slowdown
environ think industri
perform well sever largest
firm industri sell elect product
use patient align
technolog sell orthodont align
cooper compani sell contact
lens base current expect
anticip ep growth
primarili due broad-bas margin expans
effort strong revenu growth align
technolog largest health care
yet also think increas
chanc econom slowdown would
neg impact demand health care
suppli relat lower urgenc medic need
elect procedur exampl sale
dentistri orthodontist suppli
compris signific portion health care
suppli could pressur
dental procedur may less essenti end
consum mean type
procedur could delay consum feel
sub-industri robust sale growth
emerg market recent year
expect continu key growth driver
sub-industri slowdown emerg
market could significantli dampen growth
health care suppli manufactur
long run howev see sustain growth
demand health care suppli driven
age longer-liv popul increas
 medic devic regul
base index
five-year market price perform feb
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
pm et cfra reduc opinion share inc buy
strong buy given approxim rise share
sinc upgrad strong buy decemb see less upsid potenti
share reduc opinion share
buy rais price target reflect forward price-to-earnings multipl
next-twelve-month ep estim think above-p
multipl warrant given robust growth potenti product
servic market teen abroad particularli china forward price-to-earnings
multipl compar three-year rang lower ep
estim better reflect expect one-tim oper margin expens
relat legal restructur cost closur
direct-to-consum store result march arbitr decis
et cfra reiter strong buy opinion share align
technolog inc share trade midday today
news arbitr decis requir close
direct-to-consum dtc invisalign store store first pilot
novemb reach total end
allow open dtc store august financi
impact award damag result arbitr decis
result arbitr neg think impact
insignific stock reaction announc excess
believ store critic part long-term expans
henc reiter strong buy rate /kevin huang cfa
analyst research note compani news
et cfra reiter buy opinion share inc
keep target price reflect multipl
ep estim ep vs exceed
expect due higher expect revenu gross margin
lower ep start ep
manag guidanc ep fell significantli expect
due coronaviru ncov concern china repres
algn revenu compani anticip ncov result
fewer case lead million less sale despit
ncov re-affirmed could achiev long-term oper margin
volum growth target albeit lower end guidanc key uncertainti
investor durat ncov given robust respons ncov
far think stabil could come sooner investor expect
addit tax benefit relat algn reloc eu
headquart distort earn compar /kevin huang cfa
et cfra keep buy opinion share inc
keep target price base multipl
ep estim compar
rang adjust ep vs beat consensu
expect chang ep estim
ep sale grew yoy million
ahead expect total case shipment grew scanner servic
sale fell sequenti howev follow impress growth
despit surpris weak chines demand invisalign volum
grew apac led continu momentum china also encourag
see world-wide averag sell price increas sequenti
yoy basi hand continu increas sg spend
yoy increas brand awar face mount competit
opinion clear align market opportun big enough
competitor /kevin huang cfa
et cfra retain buy opinion share
cut target base multipl
ep estim compar
rang ep vs consensu
expect lower ep
ep sale grew million case shipment
grew expect itero scanner servic
sale expand key long-term growth segment china young
adult north america na weaker-than-expect demand
lead provid downbeat outlook surpris
rapidli consum sentiment china chang weak na driven
increas competit aim combat higher advertis spend
suspect soft key end market transient
lead us believ long-term growth stori remain intact albeit
et cfra maintain buy opinion share inc
lift target base multipl
ep compar rang
rais ep lower
ep ep vs higher
estim result discuss reinforc belief
growth potenti sale grew million total case shipment
itero scanner servic sale despit
larger base custom tough comparison global macroeconom concern
intern case volum grew year-over-year growth teen market
continu remain robust increas thousand note
ep like inflat includ estim gain
straumann settlement gain sdc equiti settlement off-set
partial expens relat reorgan effort /kevin
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
